Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis

INTRODUCTION: Due to the lack of highly specific and sensitive methods for diagnosing ovarian cancer at advanced stages (according to the International Federation of Gynecology and Obstetrics (FIGO) classification stage III–IV), new noninvasive biomarkers are urgently needed. This study aims to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Knapp, Paweł, Bodnar, Lubomir, Błachnio-Zabielska, Agnieszka, Reszeć, Joanna, Świderska, Magdalena, Chabowski, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811313/
https://www.ncbi.nlm.nih.gov/pubmed/33488856
http://dx.doi.org/10.5114/aoms.2018.76996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811313/
https://www.ncbi.nlm.nih.gov/pubmed/33488856
http://dx.doi.org/10.5114/aoms.2018.76996

Ejemplares similares